Mutational analysis of the highly conserved arginine within the Glu/Asp- Arg-Tyr motif of the α(1b)-adrenergic receptor: Effects on receptor isomerization and activation

Molecular Pharmacology

Volumn 57, Issue 2, 2000, Pages 219-231

  Scheer, Alexander ^a   Costa, Tommaso ^b   Fanelli, Francesca ^c   De Benedetti, Pier G ^c   Mhaouty Kodja, Sakina ^a   Abuin, Liliane ^a   Nenniger Tosato, Monique ^a   Cotecchia, Susanna ^a,d  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^d University of Lausanne Departement de Pharmacologie et de Toxicologie   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ALPHA 1B ADRENERGIC RECEPTOR; CIRAZOLINE; COMPLEMENTARY DNA; DOPAMINE; METHOXAMINE; NORADRENALIN; OXYMETAZOLINE; PHENYLEPHRINE;

ADRENERGIC SYSTEM; ANIMAL CELL; ARTICLE; CELL CULTURE; DRUG RECEPTOR BINDING; GENE MUTATION; ISOMERISM; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

ALANINE; ALLOSTERIC REGULATION; AMINO ACID MOTIFS; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMALS; ARGININE; CONSERVED SEQUENCE; COS CELLS; GTP-BINDING PROTEINS; INOSITOL PHOSPHATES; MODELS, MOLECULAR; MUTAGENESIS, SITE-DIRECTED; PHOSPHORYLATION; PROTEIN CONFORMATION; PROTEIN ISOFORMS; RECEPTORS, ADRENERGIC, ALPHA-1; TRANSFECTION;

EID: 0033974265     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. 135 sequence in rhodopsin. J Biol Chem 271:25406-25411.
2. Arora KK, Cheng Z and Catt KJ (1997) Mutations of the conserved DRS motif in the second intracellular loop of the gonadotropin-releasing hormone receptor affect expression, activation and internalization. Mol Endocrinol 11:1203-1212.
3. Baldwin JM, Schertler GF and Unger VM (1997) An alpha-carbon template for the transmembrane helices in the rhodopsin family of G protein-coupled receptors. J Mol Biol 272:144-164.
4. Ballestreros J, Kitanivich S, Guarnieri F, Davies P, Fromme BJ, Konvicka K, Chi L, Millar RP, Davidson JS, Weinstein H and Sealfon S (1998) Functional microdomains in G-protein-coupled receptors. The conserved arginine-cage motif in the gonadotropin-releasing hormone receptor. J Biol Chem 273:; 10445-10453.
5. Cohen GB, Yang T, Robinson PR and Oprian DD (1993) Constitutive activation of opsin: Influence of charge at position 134 and size at position 296. Biochemistry 32: 6111-6115.
6. Cotecchia S, Ostrowski J, Kjelsberg MA, Caron MG and Lefkowitz RJ (1992) Discrete amino acid sequences of the α1-adrenergic receptor determine the selectivity of coupling to phosphatidylinositol hydrolysis. J Biol Chem 267:1633-1639.
7. Fahmy K, Jager F, Beck M, Zvyaga TA, Sakmar TP and Siebert F (1993) Protonation states of membrane-embedded carboxylic acid groups in rhodopsin and metarhodospin II: A Fourier-transform infrared spectroscopy study of site-directed mutants. Proc Natl Acad Sci USA 90:10206-10210.
8. Fanelli F, Barbier P, Zanchetta D, De Benedetti PG and Chini B (1999a) Activation mechanism of human oxytocin receptor: A combined study of experimental and computer-simulated mutagenesis. Mol Pharmacol 56:214-225.
9. Fanelli F, Menziani MC, Cocchi M and De Benedetti PG (1995) Comparative molecular dynamics study of the seven-helix bundle arrangement of G-protein coupled receptors. J Mol Struct (THEOCHEM) 333:49-69.
10. Fanelli F, Menziani MC, Scheer A, Cotecchia S and De Benedetti PG (1998) Ab initio modeling and molecular dynamics simulation of the α1b-adrenergic receptor activation. Methods 14:302-317.
11. Fanelli F, Menziani C, Scheer A, Cotecchia S and De Benedetti PG (1999b) Theoretical study on receptor/G protein recognition: New insights into the mechanism of the α1b-adrenergic receptor activation. Int J Quantum Chem 73:71-83.
12. Franke RR, Sakmar TP, Graham RM and Khorana HG (1992) Structure and function in rhodopsin. Studies of the interaction between the rhodospin cytoplasmic domain and transducin. J Biol Chem 267:14767-14774.
13. Innamorati G, Sadeghi H, Eberle AN and Birnbaumer M (1997) Phosphorylation of the V2 vasopressin receptor. J Biol Chem 272:2486-2492.
14. Jones PG. Curtis CAM and Hulme C (1995) The function of a highly conserved arginine residue in activation of the muscarinic M1 receptor. Eur J Pharmacol 288:251-257.
15. Kenakin TP (1987) Pharmacological Analysis of Drug-Receptor Interaction. Raven Press, New York.
16. Lattion AL, Diviani D and Cotecchia S (1994) Truncation of the receptor carboxyl terminus impairs agonist-dependent phosphorylation and desensitization of the α1B-adrenergic receptor. J Biol Chem 269:22887-22893.
17. Lu ZL, Curtis CA, Jones PG, Pavia J & Hulme EC (1997) The role of the aspartate-arginine-tyrosine triad in the m1 muscarinic receptor: Mutations of aspartate 122 and tyrosine 124 decrease receptor expression but do not abolish signaling. Mol Pharmacol 51:234-241.
18. 1b adrenergic receptor mutants display different phosphorylation and internalization features. Mol Pharmacol 55:339-347.
19. Morin D, Cotte N, Balestre M-N, Mouillac B, Manning M, Breton C and Barberis C (1998) The D136A mutation of the V2 vasopressin receptor induces a constitutive activity which permits discrimination between antagonists with partial agonist and inverse agonist activities. FEBS Lett 441:470-475.
20. Obosi LA, Hen R, Beadle DJ, Bermudez I and King LA (1997) Mutational analysis of the mouse 5-HT7 receptor: Importance of the third intracellular loop for receptor-G protein interaction. FEBS Lett 412:321-324.
21. Oliveira L, Paiva ACM, Sander C and Vriend G (1994) A common step for signal transduction in G protein-coupled receptors. Trends Pharmacol Sci 15:170-172.
22. Pei G, Samama P, Lohse M, Wang M, Codina J and Lefkowitz RJ (1994) A constitutively active mutant β2-adrenergic receptor is constitutively desensitized and phosphorylated. Proc Natl Acad Sci USA 91:2699-2702.
23. Rath P, DeCaluwé LLJ, Bovee-Geurts PHM, DeGrip WJ and Rotschil KJ (1993) Fourier transform infrared difference spectroscopy of rhodopsin mutants: Light activation of rhodopsin causes hydrogen bonding change in residue aspartic acid-83 during meta II formation. Biochemistry 32:10277-10282.
24. Ren Q, Kurose H, Lefkowitz RJ and Cotecchia S (1993) Constitutively active mutants of the α2-adrenergic receptor [published erratum appears in J Biol Chem 1994; 269:1566]. J Biol Chem 268:16483-16487.
25. Rosenthal W, Antaramian A, Gilbert S and Birnbaumer M (1993) Nephrogenic diabetes insipidus. A V2 vasopressin receptor unable to stimulate adenylyl cyclase. J Biol Chem 268:13030-13033.
26. Samama P, Cotecchia S, Costa T and Lefkowitz RJ (1993) A mutation-induced activated state of the β2-adrenergic receptor. Extending the ternary complex model. J Biol Chem 268:4625-4636.
27. Scheer A, Fanelli F, Costa T, De Benedetti PG and Cotecchia S (1996) Constitutively active mutants of the α1-adrenergic receptor: Role of highly conserved polar amino acids in receptor activation. EMBO (Eur Mol Biol Organ) J 15:3566-3578.
28. Scheer A, Fanelli F, Costa T, De Benedetti PG and Cotecchia S (1997) The activation process of the α1B-adrenergic receptor: Potential role of protonation and hydrophobicity of a highly conserved aspartate. Proc Natl Acad Sci USA 94:808-813.
29. Seibold A, Dagarag M and Birnbaumer M (1998) Mutations of the DRY motif preserve β2-adrenoceptor coupling Receptors Channels 5:375-385.
30. Shi W, Sports CD, Raman D, Shirakawa S, Osawa S and Weiss ER (1998) Rhodopsin arginine-135 mutants are phosphorylated by rhodopsin kinase and bind arrestin in the absence of 11-cis-retinal. Biochemistry 37:4869-4874.
31. Theroux TL, Esbenshade TA, Peavy RD and Minneman KP (1996) Coupling efficiency of human α1-adrenergic receptor subtypes: Titration of receptor density and responsiveness with inducible and repressible expression vectors. Mol Pharmacol 50:1376-1387.
32. Unger VM, Hargrave PA, Baldwin JM and Schertler GF (1997) Arrangement of rhodopsin transmembrane alpha-helices. Nature (Lond) 389:203-206.
33. Weber G (1972) Ligand binding and internal equilibria in proteins. Biochemistry 11:864-878.
34. Weiss JM, Morgan PH, Lutz MW and Kenakin TP (1996a) The cubic ternary complex receptor-occupancy model. I. Model decsription. J Theor Biol 178:151-167.
35. Weiss JM, Morgan PH, Lutz MW and Kenakin TP (1996b) The cubic ternary complex receptor-occupancy model. III. Resurrecting efficacy. J Theor Biol 181:381-397.
36. Wess J (1997) G-protein-coupled receptors: Molecular mechanisms involved in receptor activation and selectivity of G-protein recognition. FASEB J 11:346-354.
37. Zhu SZ. Wang SZ, Hu J and El-Fakahany E (1994) An arginine conserved in most G protein-coupled receptors is essential for the function of the m1 muscarinic receptor. Mol Pharmacol 45:517-523.